Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check4 days agoChange DetectedThe footer revision tag updated from v3.6.2 to v3.6.3, indicating a newer page version.SummaryDifference0.0%

- Check11 days agoChange DetectedThe record history now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a newer release was applied to the page’s history, reflecting an update to the site’s versioning rather than changes to the study data.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment for the study has ended. The record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check32 days agoChange DetectedThe UI now displays Revision: v3.5.5, replacing v3.5.4 on the page. This reflects a small platform update to the record history view.SummaryDifference0.0%

- Check40 days agoChange DetectedThe study title was corrected to 'A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder', and the history log was updated to reflect the latest version with added sections such as Results Posted, Baseline Characteristics, Participant Flow, Document Section, IPDSharing, Eligibility, and Study Identification.SummaryDifference0.7%

- Check55 days agoChange DetectedThe study record history now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor update to the page version, reflecting changes in the ClinicalTrials.gov interface or underlying platform.SummaryDifference0.0%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.